WATSON 425 (Aspirin, Butalbital, Caffeine and Codeine 325 mg / 50 mg / 40 mg / 30 mg)

Pill imprint WATSON 425 has been identified as Aspirin, butalbital, caffeine and codeine phosphate 325 mg / 50 mg / 40 mg / 30 mg.

Aspirin/butalbital/caffeine/codeine is used in the treatment of headache and belongs to the drug class narcotic analgesic combinations. Risk cannot be ruled out during pregnancy. Aspirin/butalbital/caffeine/codeine 325 mg / 50 mg / 40 mg / 30 mg has a potential for abuse less than the drugs in schedules 1 and 2. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to moderate or low physical dependence or high psychological dependence.

See also related documents.

Imprint Search

Images for WATSON 425

Aspirin, butalbital, caffeine and codeine phosphate 325 mg / 50 mg / 40 mg / 30 mg WATSON 425
Aspirin, butalbital, caffeine and codeine phosphate
Imprint:
WATSON 425
Strength:
325 mg / 50 mg / 40 mg / 30 mg
Color:
Blue & Yellow
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Narcotic analgesic combinations
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
3 - Moderate abuse potential
Manufacturer:
Watson Pharmaceuticals

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web1)